{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T18:24:34Z","timestamp":1788114274086,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T00:00:00Z","timestamp":1424217600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s00228-015-1819-x","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T02:22:20Z","timestamp":1424139740000},"page":"411-423","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The role and utility of measuring red blood cell methotrexate polyglutamate concentrations in inflammatory arthropathies\u2014a systematic review"],"prefix":"10.1007","volume":"71","author":[{"given":"Hamid J.","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Sorich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan M.","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"McKinnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna M.","family":"Proudman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Cleland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Wiese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,18]]},"reference":[{"issue":"2","key":"1819_CR1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s002960050058","volume":"18","author":"IB Boehm","year":"1998","unstructured":"Boehm IB, Boehm GA, Bauer R (1998) Management of cutaneous lupus erythematosus with low-dose methotrexate: indication for modulation of inflammatory mechanisms. Rheumatol Int 18(2):59\u201362. doi: 10.1007\/s002960050058","journal-title":"Rheumatol Int"},{"issue":"8","key":"1819_CR2","first-page":"1568","volume":"31","author":"L Gonzalez-Lopez","year":"2004","unstructured":"Gonzalez-Lopez L, Garcia-Gonzalez A, Vazquez-Del-Mercado M, Mu\u00f1oz-Valle JF, Gamez-Nava JI (2004) Efficacy of methotrexate in ankylosing spondylitis: a randomized, double blind, placebo controlled trial. J Rheumatol 31(8):1568\u20131574","journal-title":"J Rheumatol"},{"issue":"3","key":"1819_CR3","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1172\/JCI112088","volume":"76","author":"BA Chabner","year":"1985","unstructured":"Chabner BA, Allegra CJ, Curt GA, Clendeninn NJ, Baram J, Koizumi S, Drake JC, Jolivet J (1985) Polyglutamation of methotrexate. Is methotrexate a prodrug? J Clin Invest 76(3):907\u2013912. doi: 10.1172\/JCI112088","journal-title":"J Clin Invest"},{"issue":"11","key":"1819_CR4","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1002\/art.24034","volume":"58","author":"JM Dalrymple","year":"2008","unstructured":"Dalrymple JM, Stamp LK, O\u2019Donnell JL, Chapman PT, Zhang M, Barclay ML (2008) Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 58(11):3299\u20133308. doi: 10.1002\/art.24034","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1819_CR5","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0006-291X(75)80439-6","volume":"63","author":"SA Jacobs","year":"1975","unstructured":"Jacobs SA, Adamson RH, Chabner BA, Derr CJ, Johns DG (1975) Stoichiometric inhibition of mammalian dihydrofolate reductase by the \u03b3-glutamyl metabolite of methotrexate, 4-amino-4-deoxy-N10-methylpteroylglutamyl-\u03b3-glutamate. Biochem Biophys Res Commun 63(3):692\u2013698. doi: 10.1016\/S0006-291X(75)80439-6","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"1819_CR6","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/S0021-9258(19)68121-4","volume":"257","author":"DW Fry","year":"1982","unstructured":"Fry DW, Yalowich JC, Goldman ID (1982) Rapid formation of poly-gamma-glutamyl derivatives of methotrexate and their association with dihydrofolate reductase as assessed by high pressure liquid chromatography in the Ehrlich ascites tumor cell in vitro. J Biol Chem 257(4):1890\u20131896","journal-title":"J Biol Chem"},{"issue":"3","key":"1819_CR7","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1172\/JCI111048","volume":"72","author":"J Jolivet","year":"1983","unstructured":"Jolivet J, Chabner BA (1983) Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase. J Clin Invest 72(3):773\u2013778. doi: 10.1172\/JCI111048","journal-title":"J Clin Invest"},{"issue":"5","key":"1819_CR8","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s11926-010-0120-3","volume":"12","author":"MI Danila","year":"2010","unstructured":"Danila MI, Hughes LB, Brown EE, Morgan SL, Baggott JE, Arnett DK, Bridges SL Jr (2010) Measurement of erythrocyte methotrexate polyglutamate levels: ready for clinical use in rheumatoid arthritis? Curr Rheumatol Rep 12(5):342\u2013347","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"1819_CR9","first-page":"551","volume":"43","author":"J Galivan","year":"1983","unstructured":"Galivan J, Nimec Z (1983) Effects of folinic acid on hepatoma cells containing methotrexate polyglutamates. Cancer Res 43(2):551\u2013555","journal-title":"Cancer Res"},{"issue":"3","key":"1819_CR10","first-page":"313","volume":"17","author":"P Angelis-Stoforidis","year":"1999","unstructured":"Angelis-Stoforidis P, Vajda FJ, Christophidis N (1999) Methotrexate polyglutamate levels in circulating erythrocytes and polymorphs correlate with clinical efficacy in rheumatoid arthritis. Clin Exp Rheumatol 17(3):313\u2013320","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"1819_CR11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/bcp.12209","volume":"77","author":"J Korell","year":"2014","unstructured":"Korell J, Duffull SB, Dalrymple JM, Drake J, Zhang M, Barclay ML, Stamp LK (2014) Comparison of intracellular methotrexate kinetics in red blood cells with the kinetics in other cell types. Br J Clin Pharmacol 77(3):493\u2013497. doi: 10.1111\/bcp.12209","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"1819_CR12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","volume":"158","author":"JA Hayden","year":"2013","unstructured":"Hayden JA, van der Windt DA, Cartwright JL, Cote P, Bombardier C (2013) Assessing bias in studies of prognostic factors. Ann Intern Med 158(4):280\u2013286. doi: 10.7326\/0003-4819-158-4-201302190-00009","journal-title":"Ann Intern Med"},{"key":"1819_CR13","doi-asserted-by":"crossref","unstructured":"de Rotte MC, den Boer E, de Jong PH, Pluijm SM, Bulatovic Calasan M, Weel AE, Huisman AM, Gerards AH, van Schaeybroeck B, Wulffraat NM, Lindemans J, Hazes JM, de Jonge R (2015) Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in patients with rheumatoid arthritis. Ann Rheum Dis 74(2):408\u2013414. doi: 10.1136\/annrheumdis-2013-203725","DOI":"10.1136\/annrheumdis-2013-203725"},{"key":"1819_CR14","doi-asserted-by":"crossref","unstructured":"Bulatovic Calasan M, den Boer E, de Rotte MC, Vastert SJ, Kamphuis S, de Jonge R, Wulffraat NM (2015) Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in juvenile idiopathic arthritis patients. Ann Rheum Dis\u00a074(2):402\u2013407. doi: 10.1136\/annrheumdis-2013-203723","DOI":"10.1136\/annrheumdis-2013-203723"},{"issue":"10","key":"1819_CR15","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1002\/art.22129","volume":"54","author":"T Dervieux","year":"2006","unstructured":"Dervieux T, Greenstein N, Kremer J (2006) Pharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritis. Arthritis Rheum 54(10):3095\u20133103","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1819_CR16","first-page":"156","volume":"30","author":"EL Hobl","year":"2012","unstructured":"Hobl EL, Jilma B, Erlacher L, Duhm B, Mustak M, Broll H, Hogger P, Rizovski B, Mader RM (2012) A short-chain methotrexate polyglutamate as outcome parameter in rheumatoid arthritis patients receiving methotrexate. Clin Exp Rheumatol 30(2):156\u2013163","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"1819_CR17","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.3899\/jrheum.110481","volume":"38","author":"LK Stamp","year":"2011","unstructured":"Stamp LK, Barclay ML, O\u2019Donnell JL, Zhang M, Drake J, Frampton C, Chapman PT (2011) Effects of changing from oral to subcutaneous methotrexate on red blood cell methotrexate polyglutamate concentrations and disease activity in patients with rheumatoid arthritis. J Rheumatol 38(12):2540\u20132547. doi: 10.3899\/jrheum.110481","journal-title":"J Rheumatol"},{"issue":"8","key":"1819_CR18","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1136\/ard.2004.033399","volume":"64","author":"T Dervieux","year":"2005","unstructured":"Dervieux T, Furst D, Lein DO, Capps R, Smith K, Caldwell J, Kremer J (2005) Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study. Ann Rheum Dis 64(8):1180\u20131185","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"1819_CR19","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1002\/art.20460","volume":"50","author":"T Dervieux","year":"2004","unstructured":"Dervieux T, Furst D, Lein DO, Capps R, Smith K, Walsh M, Kremer J (2004) Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis. Arthritis Rheum 50(9):2766\u20132774. doi: 10.1002\/art.20460","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1819_CR20","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2133\/dmpk.DMPK-12-RG-128","volume":"28","author":"Y Ando","year":"2013","unstructured":"Ando Y, Shimada H, Matsumoto N, Hirota T, Oribe M, Otsuka E, Ishii K, Morimoto T, Ohashi K, Ieiri I (2013) Role of methotrexate polyglutamation and reduced folate carrier 1 (RFC1) gene polymorphisms in clinical assessment indexes. Drug Metab Pharmacokinet 28(5):442\u2013445","journal-title":"Drug Metab Pharmacokinet"},{"issue":"1","key":"1819_CR21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/rheumatology\/keh401","volume":"44","author":"P Dolezalova","year":"2005","unstructured":"Dolezalova P, Krijt J, Chladek J, Nemcova D, Hoza J (2005) Adenosine and methotrexate polyglutamate concentrations in patients with juvenile arthritis. Rheumatology 44(1):74\u201379","journal-title":"Rheumatology"},{"issue":"2","key":"1819_CR22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/art.27201","volume":"62","author":"LK Stamp","year":"2010","unstructured":"Stamp LK, O\u2019Donnell JL, Chapman PT, Zhang M, James J, Frampton C, Barclay ML (2010) Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy. Arthritis Rheum 62(2):359\u2013368. doi: 10.1002\/art.27201","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1819_CR23","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/art.30080","volume":"63","author":"ML Becker","year":"2011","unstructured":"Becker ML, Gaedigk R, van Haandel L, Thomas B, Lasky A, Hoeltzel M, Dai H, Stobaugh J, Leeder JS (2011) The effect of genotype on methotrexate polyglutamate variability in juvenile idiopathic arthritis and association with drug response. Arthritis Rheum 63(1):276\u2013285","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1819_CR24","first-page":"645","volume":"31","author":"M Hoekstra","year":"2004","unstructured":"Hoekstra M, Haagsma C, Neef C, Proost J, Knuif A, van de Laar M (2004) Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis. J Rheumatol 31(4):645\u2013648","journal-title":"J Rheumatol"},{"issue":"4","key":"1819_CR25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","volume":"64","author":"H Balshem","year":"2011","unstructured":"Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S, Guyatt GH (2011) GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64(4):401\u2013406. doi: 10.1016\/j.jclinepi.2010.07.015","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"1819_CR26","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/acr.20188","volume":"62","author":"W Katchamart","year":"2010","unstructured":"Katchamart W, Johnson S, Lin HJ, Phumethum V, Salliot C, Bombardier C (2010) Predictors for remission in rheumatoid arthritis patients: a systematic review. Arthritis Care Res 62(8):1128\u20131143. doi: 10.1002\/acr.20188","journal-title":"Arthritis Care Res"},{"issue":"5","key":"1819_CR27","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/art.38331","volume":"66","author":"TN Kung","year":"2014","unstructured":"Kung TN, Dennis J, Ma Y, Xie G, Bykerk V, Pope J, Thorne C, Keystone E, Siminovitch KA, Gagnon F (2014) RFC1 80G>A is a genetic determinant of methotrexate efficacy in rheumatoid arthritis: a human genome epidemiologic review and meta-analysis of observational studies. Arthritis Rheumatol 66(5):1111\u20131120. doi: 10.1002\/art.38331","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"1819_CR28","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2217\/pgs.11.86","volume":"12","author":"LK Stamp","year":"2011","unstructured":"Stamp LK, Roberts RL (2011) Effect of genetic polymorphisms in the folate pathway on methotrexate therapy in rheumatic diseases. Pharmacogenomics 12(10):1449\u20131463. doi: 10.2217\/pgs.11.86","journal-title":"Pharmacogenomics"},{"issue":"7","key":"1819_CR29","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/ard.2008.093690","volume":"68","author":"C Salliot","year":"2009","unstructured":"Salliot C, van der Heijde D (2009) Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis 68(7):1100\u20131104. doi: 10.1136\/ard.2008.093690","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1819_CR30","first-page":"1017","volume":"27","author":"K Visser","year":"2009","unstructured":"Visser K, van der Heijde DM (2009) Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature. Clin Exp Rheumatol 27(6):1017\u20131025","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"1819_CR31","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.3899\/jrheum.090482","volume":"36","author":"L Kocharla","year":"2009","unstructured":"Kocharla L, Taylor J, Weiler T, Ting TV, Luggen M, Brunner HI (2009) Monitoring methotrexate toxicity in juvenile idiopathic arthritis. J Rheumatol 36(12):2813\u20132818. doi: 10.3899\/jrheum.090482","journal-title":"J Rheumatol"},{"issue":"Suppl 11","key":"1819_CR32","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1002\/art.38455","volume":"66","author":"H Schmeling","year":"2014","unstructured":"Schmeling H, Foeldvari I, Horneff G (2014) A39: efficacy and safety of methotrexate in oligoarticular persistent juvenile idiopathic arthritis. Arthritis Rheumatol 66(Suppl 11):S59. doi: 10.1002\/art.38455","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"1819_CR33","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/ard.2011.149765","volume":"70","author":"DT Felson","year":"2011","unstructured":"Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, Aletaha D, Allaart CF, Bathon J, Bombardieri S, Brooks P, Brown A, Matucci-Cerinic M, Choi H, Combe B, de Wit M, Dougados M, Emery P, Furst D, Gomez-Reino J, Hawker G, Keystone E, Khanna D, Kirwan J, Kvien TK, Landewe R, Listing J, Michaud K, Martin-Mola E, Montie P, Pincus T, Richards P, Siegel JN, Simon LS, Sokka T, Strand V, Tugwell P, Tyndall A, van der Heijde D, Verstappen S, White B, Wolfe F, Zink A, Boers M (2011) American College of Rheumatology\/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis 70(3):404\u2013413. doi: 10.1136\/ard.2011.149765","journal-title":"Ann Rheum Dis"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-015-1819-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-015-1819-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-015-1819-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T21:24:49Z","timestamp":1651267489000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-015-1819-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,18]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["1819"],"URL":"https:\/\/doi.org\/10.1007\/s00228-015-1819-x","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,18]]}}}